Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Cataloguing the uniqueness of an individual immune system offers a new understanding of disease.
A startup is developing the first vaccine to target patients before they develop cancer.
An old drug gets new use as an immune boost for the elderly.
The treatment suggests that the approach could be used to treat more common disorders.
A new approach shows early promise in fighting the devastating disease.
Genome-wide association studies have generated new insight into the devastating eye disease.
Autoantibodies could alert doctors to cancer development.
A polymer disc shrinks tumors in rodents by eliciting an immune attack.
With H1N1 vaccine supplies delayed, attention turns to faster-to-make “virus-like particles.”